Gefitinib encapsulation based on nano-liposomes for enhancing the curative effect of lung cancer

Gefitinib (GEB) is one of the drugs used for patients with epidermal growth factor receptor (EGFR)-positive mutations in non-small cell lung cancer (NSCLC). However, application of GEB is limited by its low water solubility, stability, and utilization rate, especially the side effects while GEB is g...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cell Cycle
Autori principali: Hu, Yanjie, Zhang, Jisong, Hu, Huihui, Xu, Shan, Xu, Li, Chen, Enguo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2020
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7781631/
https://ncbi.nlm.nih.gov/pubmed/33300430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2020.1852756
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi